What is McClain Laboratories?
McClain Laboratories LLC is a specialized entity focused on the intricate field of histopathologic evaluation of tissue biopsies. The company's core expertise lies in the detailed examination of skin, nail, and oral pathology. Their comprehensive services encompass meticulous gross examination and precise diagnosis, all delivered by a team of highly knowledgeable and professional staff committed to providing superior customer service. To enhance diagnostic capabilities, McClain Laboratories employs advanced techniques, including epidermal nerve fiber density analysis, microorganism detection, immunohistochemistry, and direct immunofluorescence. These sophisticated methodologies are designed to serve healthcare professionals and institutions that require expert pathology services for accurate and reliable diagnostic outcomes.
How much funding has McClain Laboratories raised?
McClain Laboratories has raised a total of $181K across 1 funding round:
Debt
$181K
Debt (2021): $181K with participation from PPP
What's next for McClain Laboratories?
The substantial late-stage funding, characterized as a major strategic investment, positions McClain Laboratories for significant scaling and market expansion. This capital infusion is likely to fuel advancements in their diagnostic technologies, potentially broadening the scope of their specialized pathology services. The company may also focus on enhancing its operational infrastructure and expanding its reach to a wider network of healthcare providers and institutions. Strategic partnerships and further technological integration are probable avenues for growth, solidifying McClain Laboratories' role as a key player in the diagnostic pathology sector.
See full McClain Laboratories company page
